Rpl36 is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
Ribosomal Protein L36 (RPL36) is a component of the 60S ribosomal subunit and plays essential roles in protein synthesis. RPL36 is one of the smaller ribosomal proteins and is located at the interface between the large and small ribosomal subunits. While primarily known for its role in translation, emerging research suggests RPL36 may have functions relevant to neurodegenerative diseases through its involvement in ribosome dynamics and cellular stress responses. [@ribosomal2022]
Molecular Characteristics
RPL36 is a 60S ribosomal protein encoded by the RPL36 gene. [@translational2021]
Structural Features
Molecular Weight: Approximately 12.4 kDa
Amino Acids: 105 amino acids
Isoforms: Multiple isoforms including RPL36A and RPL36B variants
Subcellular Localization: Cytoplasmic, associated with the 60S ribosomal subunit
Domain Structure: Contains conserved ribosomal protein L36 domain with zinc finger motif
Biological Functions
Protein Synthesis
RPL36 contributes to the function of the 60S ribosomal subunit: [@ribosome2023]
Subunit Interface: Located at the subunit interface, RPL36 participates in inter-subunit communication during translation
Peptidyl Transferase Activity: Contributes to the catalytic center of the ribosome
Translation Fidelity: RPL36 may play roles in maintaining reading frame fidelity
Ribosomal Assembly
60S Assembly: RPL36 is incorporated into the developing 60S subunit
Late Assembly Factor: The protein is involved in late stages of ribosomal assembly
Role in Neurodegeneration
Translation Defects in Neurodegeneration
Dysregulated translation is a hallmark of many neurodegenerative diseases. RPL36 may contribute through: [@mtor2022]
Altered Translation Kinetics: Changes in RPL36 function may affect translation rates
Synaptic Translation: Local protein synthesis at synapses requires functional ribosomes
Stress Response: Ribosomal proteins can be recruited to stress granules under cellular stress
Alzheimer's Disease
RPL36 may be relevant to Alzheimer's disease through: [@stress2021]
[mTOR](/mechanisms/mtor-signaling-pathway) Pathway Dysregulation: mTOR signaling affects ribosomal protein function and translation
Synaptic Protein Synthesis: Impaired RPL36 function may affect synthesis of synaptic proteins
Protein Aggregation: Ribosomal dysfunction may contribute to protein aggregation
Parkinson's Disease
In Parkinson's disease:
Mitochondrial Translation: RPL36 function may affect mitochondrial protein synthesis
[Alpha-Synuclein](/proteins/alpha-synuclein) Translation: Altered translation may affect alpha-synuclein expression
Neuronal Energy Metabolism: Protein synthesis requires significant energy in [neurons](/entities/neurons)
Amyotrophic Lateral Sclerosis
In ALS:
Stress Granule Dynamics: RPL36 may be involved in stress granule formation
RNA Metabolism: Intersects with RNA binding protein pathology in ALS
Motor Neuron Vulnerability: Motor neurons may be sensitive to translation defects
Therapeutic Implications
Research Directions
Translation Modulation: Understanding RPL36 function may reveal therapeutic targets
Selective Vulnerability: Motor neuron-specific vulnerabilities may involve ribosomal proteins
The study of Rpl36 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, Structure of the human 80S ribosome (2020) (2020)](https://doi.org/10.1038/s41586-020-2351-2)
[Unknown, Ribosomal proteins in neurodegeneration (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35452341/)
[Unknown, Translational dysfunction in Alzheimer's disease (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/33890123/)
[Unknown, Ribosome quality control in neurodegenerative diseases (2023) (2023)](https://pubmed.ncbi.nlm.nih.gov/36789012/)
[Unknown, mTOR signaling and translation in neurons (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35123456/)
[Unknown, Stress granules in neurodegeneration (2021) (2021)](https://pubmed.ncbi.nlm.nih.gov/34212345/)